What are the diagnostic criteria for acute coronary syndrome (ACS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Acute Coronary Syndrome

Acute coronary syndrome (ACS) is diagnosed when a patient presents with symptoms of myocardial ischemia (typically chest pain or anginal equivalents) combined with either ECG changes or elevated cardiac biomarkers, specifically high-sensitivity cardiac troponin above the 99th percentile upper reference limit. 1

Core Diagnostic Components

The diagnosis requires integration of three key elements 1, 2:

1. Clinical Presentation

  • Chest discomfort described as pain, pressure, tightness, or burning is the leading symptom, present in approximately 79% of men and 74% of women 1, 3
  • Anginal equivalents include dyspnea, epigastric pain, pain radiating to the left arm, or diaphoresis 1, 3
  • Atypical presentations occur in approximately 40% of men and 48% of women, particularly in elderly patients, women, and those with diabetes or chronic renal failure 1, 3
  • Symptoms exacerbated by physical exertion or relieved by rest/nitrates support the diagnosis 1

2. Electrocardiogram (ECG) Findings

The 12-lead ECG must be obtained within 10 minutes of first medical contact and immediately interpreted 1, 3:

For STEMI (ST-Segment Elevation ACS):

  • Persistent ST-segment elevation (>20 minutes) in two contiguous leads 1
  • Specific thresholds: ≥0.25 mV in men <40 years, ≥0.2 mV in men ≥40 years, or ≥0.15 mV in women in leads V2-V3; ≥0.1 mV in all other leads 4
  • New or presumed new left bundle branch block with clinical suspicion of ongoing ischemia 1, 4

For NSTE-ACS (Non-ST-Segment Elevation ACS):

  • Transient ST-segment elevation 1
  • Persistent or transient ST-segment depression 1
  • T-wave inversion, flat T waves, or pseudo-normalization of T waves 1
  • The ECG may be completely normal in up to 41% of NSTE-ACS cases 1, 3

3. Cardiac Biomarkers

High-sensitivity cardiac troponin (hs-cTn) T or I is the preferred biomarker 1, 5:

  • Detection of a rise and/or fall in troponin values with at least one value above the 99th percentile upper reference limit 1, 5
  • Serial measurements are essential—repeat at 3 hours, 6-9 hours, and 24 hours after presentation 1
  • Elevated troponin distinguishes NSTEMI from unstable angina 1, 2

Additional Supporting Criteria

At least one of the following must accompany elevated troponin 1, 5:

  • Symptoms of myocardial ischemia 1
  • New ischemic ECG changes 1
  • Development of pathological Q waves on ECG 1
  • Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with ischemic etiology 1
  • Intracoronary thrombus detected on angiography or autopsy 1

Classification Within ACS Spectrum

Once ACS is suspected, patients are categorized based on ECG and troponin 1:

STEMI (ST-Segment Elevation Myocardial Infarction)

  • Persistent ST elevation (>20 minutes) on ECG 1
  • Reflects acute total or subtotal coronary occlusion 1
  • Accounts for approximately 30% of ACS cases 3
  • Requires immediate reperfusion therapy 1, 3

NSTEMI (Non-ST-Segment Elevation Myocardial Infarction)

  • No persistent ST elevation but elevated troponin above 99th percentile 1
  • ECG may show ST depression, T-wave changes, or be normal 1
  • Reflects cardiomyocyte necrosis from partial or intermittent coronary occlusion 1, 3

Unstable Angina

  • Myocardial ischemia without troponin elevation (no cardiomyocyte necrosis) 1, 2
  • Increasingly rare diagnosis with high-sensitivity troponin assays 1, 2
  • Patients have substantially lower risk of death compared to NSTEMI 1

Critical Diagnostic Pitfalls

Normal ECG does not exclude ACS: Nearly two-thirds of ischemic episodes are clinically silent, and a completely normal ECG occurs in a significant proportion of NSTE-ACS patients 1, 3. Ischemia in the circumflex artery territory or isolated right ventricular ischemia frequently escapes standard 12-lead ECG detection 1.

Consider additional ECG leads: Record leads V7-V9 for suspected posterior MI and leads V3R-V4R for suspected right ventricular involvement in inferior MI 1, 4.

ACS can occur with non-obstructive coronary arteries: Approximately 5-10% of ACS cases occur without obstructive coronary artery disease on angiography, particularly in women, due to coronary vasospasm, spontaneous dissection, embolism, or microvascular dysfunction 2, 5.

Precipitating conditions must be identified: Anemia, infection, fever, thyroid disorders, tachyarrhythmias, or severe hypertension can precipitate or exacerbate ACS and must be addressed 1.

Risk Stratification Tools

Use validated risk scores to guide management decisions 1, 2:

  • HEART score (History, ECG, Age, Risk factors, Troponin) is specifically designed for emergency department chest pain evaluation 1, 2
  • TIMI score (Thrombolysis in Myocardial Infarction) 1
  • GRACE score (Global Registry of Acute Cardiac Events) 1

These scores incorporate multiple variables and are more accurate than any single clinical element for predicting major adverse cardiac events 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Coronary Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

ST Elevation Criteria for Diagnosing STEMI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria and Classification of Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.